首页 | 本学科首页   官方微博 | 高级检索  
检索        

M受体及相关选择性药物研究进展
引用本文:史一鸣,钮因尧,陆阳.M受体及相关选择性药物研究进展[J].国外医学(药学分册),2009(5):355-361.
作者姓名:史一鸣  钮因尧  陆阳
作者单位:上海交通大学医学院药学系;
摘    要:毒草碱受体(M受体)是体内重要的G蛋白偶联受体之一,有M1~M5五种药理学亚型,各亚型在体内的分布和功能不同,受体蛋白结构和信号转导机制也有差异。对M受体、相关选择性药物及受体一配体作用位点的研究,将为设计以M受体各亚型为靶标的选择性药物提供帮助,对临床治疗多种M受体功能紊乱的疾病,如阿尔茨海默病等具有重要意义。

关 键 词:毒蕈碱受体  胆碱能药物  亚型选择性

Muscarinic receptors and related selective drugs: research advances
SHI Yi-ming,NIU Yin-yao,LU Yang.Muscarinic receptors and related selective drugs: research advances[J].Foreign Medical Sciences(Section of Pharmarcy),2009(5):355-361.
Authors:SHI Yi-ming  NIU Yin-yao  LU Yang
Institution:SHI Yi-ming,NIU Yin-yao,LU Yang (Department of Pharmacy,School of Medicine,Shanghai Jiaotong University,Shanghai 200025,China)
Abstract:Muscarinic receptors(M receptors),the important members of G protein-coupled receptors,comprise five subtypes M1-M5.Each subtype has different distribution and biological function in vivo,and their protein structures and signal transduction pathways are distinct as well.Studies on M receptors,related selective drugs and receptor-ligand binding sites could provide some information helpful to the design of selective compounds targeting single M receptor subtype.This is very important to develop clinical thera...
Keywords:muscarinic receptors  cholinergic drugs  subtype selectivity  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号